腹腔镜脾脏切除术治疗肝硬化脾功能亢进症疗效分析

doi:10.3969/j.issn.1672-5069.2016.06.025

Abstract

Wei Wei，Zhang Xiaogang.. Laparoscopic splenectomy in the treatment of patients with liver cirrhosis and hypersplenism[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 728-729.

[1] Martins GL，Bernardes JP，Rovella MS，et al. Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option. World J Gastroenterol，2015，21（20）:6391-6397.
[2] 乔谦，顾澄宇，吴鸣宇，等. 肝脾联合切除治疗肝癌合并肝硬化脾功能亢进的Meta分析. 中华肝胆外科杂志，2011，17（3）:203-207.
[3] 姜青峰，王要轩，李珂，等. 腹腔镜脾切除联合贲门周围血管离断术治疗门静脉高压症临床分析. 中华实用诊断与治疗杂志， 2014，28（5）:469-470.
[4] 徐明洲. 部分性脾动脉栓塞联合自体骨髓干细胞移植治疗肝硬化脾功能亢进的临床研究.中国现代医生，2014，52（3）:152-153.
[5] Hong D，Cheng J，Wang Z，et al. Comparison of two laparoscopic splenectomy plus pericardial devascularization techniques for management of portal hypertension and hypersplenism. Surg Endosc，2015，29（12）:3819-3826.
[6] Cai Y，Liu X，Peng B. A novel method for laparoscopic splenectomy in the setting of hypersplenism secondary to liver cirrhosis:ten years'experience. World J Surg，2014，38（11）:2934-2439.
[7] Shi R，Zhang YM，Zhu ZJ，et al. Synchronous splenectomy and hepatectomy in patients with hepatocellular carcinoma，hypersplenism and liver cirrhosis. Hepatogastroenterology，2014，61（133）:1363-1367.
[8] 孙国明. 肝脾联合切除治疗肝癌伴肝硬化脾功能亢进的安全性和疗效. 中国现代普通外科进展，2016，19（2）:145-146.
[9] Martins GL，Bernardes JP，Rovella MS，et al. Radiofrequency ablation for treatment of hypersplenism:A feasible therapeutic option. World J Gastroenterol，2015，21（20）:6391-6397.
[10] Jiang X，Gao F，Ma Y，et al. Percutaneous microwave ablation in the spleen for treatment of hypersplenism in cirrhosis patients. Dig Dis Sci，2016，61（1）:287-292.
[11] 成静，付强，张永磊，等. 腹腔镜脾脏切除术治疗老年肝硬化脾功能亢进的临床疗效. 中国老年学杂志，2014，34（17）:4860-4862.
[12] 余昌达，叶琳，胡东，等. 腹腔镜与开腹手术治疗肝硬化门静脉高压脾功能亢进的效果比较. 山东医药，2013，53（20）:57-59.
[13] 吴武军，于咏田，杜立学，等. 脾腔小口径分流联合断流术对肝硬化门静脉高压症患者肝血流动力学和储备功能的影响. 实用肝脏病杂志，2016，19（2）:196-199.
[14] Okazaki T，Hifumi T，Manabe A，et al. Invasive group B streptococcal infection in a patient with post splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension. World J Emerg Med，2016，7（1）:68-70.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[3]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[4]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[5]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[6]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[7]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[8]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[9]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[10]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[11]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[12]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[13]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[14]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[15]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.

Laparoscopic splenectomy in the treatment of patients with liver cirrhosis and hypersplenism

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments